• Diagnostical and pharmacoeconomical prevalence of the screening pulseoxymetry in newborns with critical heart defects

Diagnostical and pharmacoeconomical prevalence of the screening pulseoxymetry in newborns with critical heart defects

PERINATOLOGIYA I PEDIATRIYA. 2016.4(68):50-54; doi 10.15574/PP.2016.68.50 
 

Diagnostical and pharmacoeconomical prevalence of the screening pulseoxymetry in newborns with critical heart defects


Dudnуk V. M., Zborovska O. O.

Pirogov Vinnytsia National Medical University, Ukraine


Critical heart defects in case of late diagnostic lead to fatal results in newborn period. Most of the critical heart abnormalities don't have clinical presentation within first days of life, and tendency of earl leaving of the delivery house influence on manifestation of the symptoms of the heart failure can be occurred out of the hospital, that sharply decrease prognosis for the survive. That is why we have a need of the diagnostic methods that supports criteria of the screening test and add present methods of the earl diagnostic of the critical heart defects in newborns. In the article we presented modern data of the method of screening pulseoxymetry in medicine through over the world and its diagnostically and pharmacoeconomically prevalence while the investigation of the newborns with critical heart defects.


Key words: critical congenital heart defects, screening pulseoxymetry, newborns.


References

1. Zin'kovskiy MF. 2009. Congenital heart defects. Kiev, Kniga Plyus: 1170.

2. Zubov LA. 2008. Critical condition of congenital heart defects in newborns. Meditsina neotlozhnyih sostoyaniy. 4(17): 107-113.

3. Maydannik VG, Haytovich MV. 2010. Diagnostics of congenital heart defects: current situation and prospects. Pediatriya, akusherstvo ta ginekologiya. 1: 31-35.

4. Jawin VAng HL, Omar A et al. 2015. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country. PLoS One. 16. https://doi.org/10.1371/journal.pone.0137580.

5. Bhola K, Kluckow M, Evans N. 2014. Post-implementation review of pulse oximetry screening of well newborns in an Australian tertiary maternity hospital. J Paediatr Child Health. 50(11): 920-925. https://doi.org/10.1111/jpc.12651; PMid:24923996

6. Turska-Kmieс A, Borszewska-Kornacka M, Blaz W, Kawalec W, Zuk M et al. 2012. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: xperience of the POLKARD pulse oximetry programme 2006–2008 in Poland. Kardiologia Polska. 70(4): 370–376.

7. Hoffman J. 2011. It is time for routine neonatal screening by pulse oximetry. Neonatology. 99: 1–9. https://doi.org/10.1159/000311216; PMid:20523077

8. De-Wahl Granelli A, Wennergren M, Sandberg K et al. 2009. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 338: 145-149. https://doi.org/10.1136/bmj.a3037; PMid:19131383 PMCid:PMC2627280

9. Kumar RK. 2016. Screening for congenital heart disease in India: Rationale, practical challenges, and pragmatic strategies. Ann Pediatr Cardiol. 9(2): 111-114. https://doi.org/10.4103/0974-2069.181499; PMid:27212843 PMCid:PMC4867793

10. Nadas AS, Fyler DC. 2006. Hypoxemia. In: Keane JF, Lock JE, Fyler DC, editors. Nada's pediatric cardiology. 2nd edition. Philadelphia: Saunders Elsevier: 97–101.

11. Hoke TR, Donohue PK, Bawa PK et al. 2002. Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatr Cardiol. 23: 403-409. https://doi.org/10.1007/s00246-002-1482-8; PMid:12170356

12. Ewer AK, Furmston AT, Middleton LJ et al. 2012. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess. 16(2). https://doi.org/10.3310/hta16020.

13. Ewer AK, Middleton LJ, Furmston AT et al. 2011. PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. 378: 785-794.

14. Mahle WT, Newburger JW, Matherne GP et al. 2009. Role of pulse -oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. Circulation. 120: 447-458. https://doi.org/10.1161/CIRCULATIONAHA.109.192576; PMid:19581492

15. Mahle WT, Newburger JW, Matherne GP et al. 2009. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP. American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research; American Academy of Pediatrics Section on Cardiology and Cardiac Surgery; Committee on Fetus and Newborn. Pediatrics. 124(2): 823-836. https://doi.org/10.1542/peds.2009-1397; PMid:19581259

16. Kemper AR, Mahle WT, Martin GR et al. 2011. Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics. 128(5): 1259-1267. https://doi.org/10.1542/peds.2011-1317; PMid:21987707